AJP - Heart Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (October 5, 2007). doi:10.1152/ajpheart.00764.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/6/H3448    most recent
00764.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ansari, H. R.
Right arrow Articles by Mustafa, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ansari, H. R.
Right arrow Articles by Mustafa, S. J.
Submitted on July 3, 2007
Accepted on October 2, 2007

Involvement of COX-1 in A3 adenosine receptor-mediated contraction through endothelium in mice aorta

Habib R. Ansari1, Ahmed Nadeem1, Stephen L. Tilley2, and S. Jamal Mustafa1*

1 Physiology and Pharmacology, West Virginia University, Morgantown, West Virginia, United States
2 Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States

* To whom correspondence should be addressed. E-mail: smustafa{at}hsc.wvu.edu.

We investigated whether A3 adenosine receptor (A3AR) is involved in endothelium mediated contraction through cyclooxygenases (COXs) with the use of wild type (WT) and A3 knock-out (A3KO) mice aorta. A3AR selective agonist, Cl-IBMECA produced a concentration-dependent contraction (EC50: 2.9±0.2x10-9 M) in WT mouse aorta with intact endothelium (+E), and negligible effects in A3KO (+E) aorta. At 10-7 M, contractions produced by Cl-IBMECA were 29% in WT (+E), while being insignificant in A3KO (+E) aorta. Cl-IBMECA-induced responses were abolished in endothelium denuded tissues (-E) both in WT and A3KO aorta. A3AR gene and protein expression were reduced by 74% and 72% (p<0.05), respectively in WT (-E) as compared to WT (+E) aorta while being undetected in A3KO (+E/-E) aorta. Indomethacin (non-specific COXs blocker, 10-5 M), SC-560 (specific COX-1 blocker, 10-8 M), SQ 29549 [thromboxane prostanoid receptor (TP) antagonist (10-6 M)] and furegrelate [thromboxane synthase (TS) inhibitor, 10-5 M] inhibited Cl-IBMECA-induced contraction significantly. Cl-IBMECA-induced TXB2 production was attenuated significantly by indomethacin, SC-560 and furegrelate in WT (+E) aorta while having negligible effects in A3KO (+E) aorta. NS-398 (specific COX-2 blocker) produced negligible inhibition of Cl-IBMECA induced contraction both in WT (+E) and A3KO (+E) aorta. Cl-IBMECA-induced increase in COX-1 and TP receptor expression was significantly inhibited by MRS1523, a specific A3AR antagonist in WT (+E) aorta. Expression of both A3AR and COX-1 was located mostly on endothelium of WT and A3KO (+E) aorta. These results demonstrate for the first time the involvement of COX-1 pathway in A3AR- mediated contraction via endothelium.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.